Page 5 - பிபே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிபே. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிபே Today - Breaking & Trending Today

At Least Three Lawmakers Test Positive for Covid-19 After Capitol Attack


Updated Jan. 12, 2021 5:03 pm ET
WASHINGTON At least three lawmakers who sheltered in a secure room during last week’s storming of the Capitol said they have since tested positive for Covid-19, adding to fears about the virus’s spread during the attack.
The lawmakers, all Democrats, said they had fled during the attack to the room where Republican lawmakers refused to wear masks. A video posted by Punchbowl News shows Rep.
Lisa Blunt Rochester
(D., Del.) in the room offering masks to a group of House Republicans, who decline to put them on.
The Capitol’s physician told lawmakers and staff this weekend that those who were in the room might have been exposed to someone infected with Covid-19. ....

Capitol Hill , District Of Columbia , United States , Markwayne Mullin , Laura Kammermann , Marjorie Taylor Greene , Bonnie Watson Coleman , Pramila Jayapal , Brad Schneider , Andy Biggs , Joe Biden , Scott Perry , Andrew Duehren , Watson Coleman , Graeme Jennings Associated , Dow Jones Company Inc , Michael Brochstein Zuma , Zuma Press , Punchbowl News , Lisa Blunt Rochester , House Republicans , Some Democrats , Associated Press , President Trump , Wall Street Journal , All Rights ,

Bristol Myers Looks to Its Drug Pipeline to Turbocharge Growth


Bristol Myers Squibb
could be on track to break out.
The drugmaker said Monday that its current pipeline of drugs could generate $25 billion in annual revenue, enough to replace lost revenue from expired patents by 2030.
Bristol (ticker: BMY) also boosted its share-buying program by $2 billion.
The company spent the last year in acquisition mode, with a $74 billion deal for Celgene in 2019 and a $13 billion deal for MyoKardia more recently. With $22 billion of cash on hand, there’s room for more of that, according to Bristol CEO Giovanni Caforio.
“We will continue to look for midsize bolt-on deals that further strengthen our object to grow the company into the second half of the decade,” Caforio said at JPMorgan’s healthcare conference on Monday. ....

George Frey Bloomberg , Raymond Jame , Raymond James , Giovanni Caforio , Liz Moyer , Bristol Myers Squibb , Myers Squibb , Healthcare Life Sciences , Biological Therapy , Healthcare Provision , Biotech And Pharma , Merck Amp , S Ampp 500 Index , Health Care , Life Sciences , ஜார்ஜ் ஃப்ரீ ப்ளூம்பெர்க் , ரேமஂட் ஜேம் , ரேமஂட் ஜேம்ஸ் , லிஸ் மோயர் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , மைஸ் ஸ்க்விப்ப் , உயிரி தொழில்நுட்பவியல் , சுகாதாரம் வாழ்க்கை அறிவியல் , உயிர் மருந்துகள் , உயிரியல் சிகிச்சை , சுகாதாரம் ஏற்பாடு ,

Sarepta Stock Gains as CEO Explains Setback for Gene Therapy


Instead of taking his listeners through a leisurely survey of the outlook for
Sarepta Therapeutics,
CEO Doug Ingram dove into a Monday talk for investors with a review of what went wrong in Sarepta’s trial of its gene therapy for Duchenne muscular dystrophy. The study’s failure to show a statistically significant strength improvement in children who were treated caused Sarepta stock (ticker: SRPT) to drop by half on Friday.
“I was not merely disappointed.” Ingram told his audience at the J.P. Morgan Healthcare Conference. “I was, to be frank, utterly gobsmacked.” Analysis soon convinced Ingram and his colleagues that the study’s failure to prove a benefit resulted from bad luck, not the treatment’s failure. ....

Doug Ingram , Drug Administration , Sarepta Therapeutics , Nasdaq Composite , Bill Alpert , Healthcare Life Sciences , Biological Therapy , Healthcare Provision , Corporate Industrial News , Senior Level Management , Political General News , Genetic Disorders , Medical Conditions , Medical Treatments Procedures , Content Types , Factiva Filters , C Ampe Industry News Filter , Biotech And Pharma , Nasdaq Composite Index , Industrial News , General News , Medical Treatments , Health Care , Life Sciences , டக் இஂக்ரம் , சாறெப்டா சிகிச்சை ,